Suzhou Novoprotein Scientific Co., Ltd. (688137)

Overview

Founded in 2009 and headquartered in Suzhou, China, Novoprotein Scientific Inc. is at the forefront of biotechnological innovation, focusing on the research, development, production, and sale of vital raw materials and technical solutions tailored for bio-pharmaceutical enterprises and research institutions across Asia, Europe, the United States, and Oceania. The company has cemented its role in the biopharmaceutical sector by offering a comprehensive range of products and services that cater to the needs of mRNA vaccines and drugs, in vitro diagnostics, biological drugs, and basic research in life sciences among other fields.

Products and Services

Novoprotein Scientific Inc. provides a broad spectrum of products and technical services designed to meet the rigorous demands of the biopharmaceutical industry:

• Cytokines, Target Proteins, mRNA Vaccine and Drug Enzymes, Recombinant Antibodies, Molecular Enzymes and Reagents: These foundational components are crucial for the development and production of a wide range of therapeutics and diagnostics.
• Gene and Cell Therapy Products: Supplying state-of-the-art tools and materials for gene editing and cell therapy applications, facilitating groundbreaking treatments.
• Molecular Research and Diagnosis Products: Offering advanced solutions for molecular biology research and diagnostic applications, enhancing the understanding and detection of diseases.
• SRAS-CoV-2 and SARS-CoV-2 Related Products: Providing essential resources for the research and development of treatments and vaccines for COVID-19.
• Custom Service Offerings: Including protein expression and purification, antibody and industrial strain process development, stable cell line development, vaccine development, VLP protein production, protein crystallization, protein modification and labeling, MHC I-peptide complex protein preparation, and mRNA synthesis custom services.

Through these comprehensive product lines and custom services, Novoprotein Scientific Inc. effectively supports the biopharmaceutical sector in overcoming current challenges and pursuing novel therapeutic approaches.